Bavarian Nordic PE Ratio 2016-2021 | BVNRY
Current and historical p/e ratio for Bavarian Nordic (BVNRY) from 2016 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bavarian Nordic PE ratio as of October 26, 2021 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
|Bavarian Nordic PE Ratio Historical Data
||TTM Net EPS
||Medical - Biomedical and Genetics
Bavarian Nordic A/S is a biotechnology company. It focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company's product pipeline consists of IMVAMUNE(R), PROSTVAC (R), MVA-BN Brachyury, CV-301, MVA-BN Filo which are in clinical trial stage. Bavarian Nordic A/S is headquartered in Kvistgaard, Denmark.